ES2148991T3 - Oligosacaridos oxidados. - Google Patents

Oligosacaridos oxidados.

Info

Publication number
ES2148991T3
ES2148991T3 ES97928373T ES97928373T ES2148991T3 ES 2148991 T3 ES2148991 T3 ES 2148991T3 ES 97928373 T ES97928373 T ES 97928373T ES 97928373 T ES97928373 T ES 97928373T ES 2148991 T3 ES2148991 T3 ES 2148991T3
Authority
ES
Spain
Prior art keywords
oligosaccharides
oxidized oligosaccharides
oxidized
oxidated
orc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97928373T
Other languages
English (en)
Inventor
Wilson Harvey
Lowell Saferstein
David Wiseman
Paul William Watt
Nicholas Light
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Medical Ltd
Original Assignee
Johnson and Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Medical Ltd filed Critical Johnson and Johnson Medical Ltd
Application granted granted Critical
Publication of ES2148991T3 publication Critical patent/ES2148991T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C08B15/04—Carboxycellulose, e.g. prepared by oxidation with nitrogen dioxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G3/00—Glycosides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA OLIGOSACARIDOS QUE TIENEN PESOS MOLECULARES EN LA ESCALA DE 1.000 A 50.000, Y QUE SE OBTIENEN POR HIDROLISIS PARCIAL DE POLISACARIDOS OXIDADOS, TALES COMO LA CELULOSA REGENERADA OXIDADA (ORC). LOS OLIGOSACARIDOS SON UTILES COMO VENDAJES DE HERIDAS O JUNTO CON ELLOS, Y PARA LA FIJACION DE PEPTIDOS O PROTEINAS.
ES97928373T 1996-06-28 1997-06-27 Oligosacaridos oxidados. Expired - Lifetime ES2148991T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9613683A GB2314840B (en) 1996-06-28 1996-06-28 Oxidized oligosaccharides and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2148991T3 true ES2148991T3 (es) 2000-10-16

Family

ID=10796095

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97928373T Expired - Lifetime ES2148991T3 (es) 1996-06-28 1997-06-27 Oligosacaridos oxidados.

Country Status (16)

Country Link
EP (1) EP0907664B1 (es)
JP (2) JP4302187B2 (es)
KR (1) KR20000022286A (es)
AT (1) ATE195742T1 (es)
AU (1) AU725296B2 (es)
BR (1) BR9710003A (es)
CA (1) CA2258849C (es)
CZ (1) CZ294839B6 (es)
DE (1) DE69702911T2 (es)
ES (1) ES2148991T3 (es)
GB (1) GB2314840B (es)
GR (1) GR3034853T3 (es)
HU (1) HUP9903404A3 (es)
PL (1) PL189194B1 (es)
PT (1) PT907664E (es)
WO (1) WO1998000446A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112320B1 (en) 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
GB2344519B (en) * 1998-12-07 2004-05-19 Johnson & Johnson Medical Ltd Sterile therapeutic compositions
GB9900150D0 (en) 1999-01-05 1999-02-24 Unilever Plc Treatment for fabrics
GB2354708B (en) * 1999-10-01 2004-06-02 Johnson & Johnson Medical Ltd Compositions for the treatment of wound contracture
AU784607B2 (en) * 2000-05-12 2006-05-11 Systagenix Wound Management Ip Co. B.V. Free radical scavenging compositions
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
AU782756B2 (en) * 2000-05-12 2005-08-25 Systagenix Wound Management Ip Co. B.V. Solid composition exhibiting selective binding to dissolved iron
US7262181B2 (en) * 2001-04-30 2007-08-28 Beijing Textile Research Institute Water soluble cellulose etherified derivatives styptic materials
US20030118651A1 (en) * 2001-12-21 2003-06-26 Jampani Hanuman B. Bio-compatible means for controlled drug delivery to tissue and method of use
US20030124087A1 (en) * 2001-12-26 2003-07-03 Amitie Co. Ltd. Anti-adhesion barrier
US20040101547A1 (en) * 2002-11-26 2004-05-27 Pendharkar Sanyog Manohar Wound dressing containing aldehyde-modified regenerated polysaccharide
US7252837B2 (en) 2002-06-28 2007-08-07 Ethicon, Inc. Hemostatic wound dressing and method of making same
US7279177B2 (en) 2002-06-28 2007-10-09 Ethicon, Inc. Hemostatic wound dressings and methods of making same
US8461410B2 (en) 2002-09-11 2013-06-11 Ethicon, Inc. Wound dressing materials comprising complexes of anionic polysaccharides with silver
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
GB2393120A (en) * 2002-09-18 2004-03-24 Johnson & Johnson Medical Ltd Compositions for wound treatment
US8685943B2 (en) 2003-03-12 2014-04-01 Hill's Pet Nutrition, Inc. Methods for reducing diarrhea in a companion animal
US7019191B2 (en) 2003-03-25 2006-03-28 Ethicon, Inc. Hemostatic wound dressings and methods of making same
DE10319808A1 (de) * 2003-04-28 2004-11-18 Friedrich-Schiller-Universität Jena Verwendung von Polysaccharid-Derivaten als Mittel zur Stimulierung der Zellproliferation
GB2408206B (en) 2003-11-18 2007-11-28 Johnson & Johnson Medical Ltd Antioxidant and antimicrobial wound dressing materials
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
CN1886427B (zh) 2003-11-28 2012-05-23 伊士曼化工公司 纤维素共聚体和氧化方法
JP2008513153A (ja) * 2004-09-17 2008-05-01 デイビッド・エム・ディクソン 創傷治療用ドレッシング材及びその使用方法
AU2005295367B2 (en) 2004-10-20 2010-12-02 Ethicon, Inc. A reinforced absorbable multilayered fabric for use in medical devices and method of manufacture
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
CN102091347A (zh) 2004-10-20 2011-06-15 伊西康公司 可吸收的止血物
WO2007026341A1 (en) * 2005-09-02 2007-03-08 Alltracel Development Services Limited A method for preparing polyanhydroglucuronic acid and/or salts thereof
JP4975996B2 (ja) * 2005-09-30 2012-07-11 東邦化学工業株式会社 カチオン変性ペクチン及び該物質を含む化粧料組成物
GB2444232A (en) 2006-11-30 2008-06-04 Ethicon Inc Wound dressing compositions comprising cell lysates
US20090074837A1 (en) * 2007-09-19 2009-03-19 Ut-Battelle, Llc Bioresorbable Calcium-Deficient Hydroxyapatite Hydrogel Composite
US9376648B2 (en) 2008-04-07 2016-06-28 The Procter & Gamble Company Foam manipulation compositions containing fine particles
JP2010284216A (ja) * 2009-06-09 2010-12-24 Hogi Medical:Kk カルボキシメチルセルロース構造体及びその製造方法
JP5818055B2 (ja) * 2010-03-17 2015-11-18 静岡県公立大学法人 トリアセチルセルロースブロック共重合体、その中間体、充填剤、および、界面活性剤
WO2012132903A1 (ja) * 2011-03-30 2012-10-04 日本製紙株式会社 セルロースナノファイバーの製造方法
DE102011007528A1 (de) * 2011-04-15 2012-10-18 Aesculap Aktiengesellschaft Thixotrope Zusammensetzung, insbesondere zur postchirurgischen Adhäsionsprophylaxe
WO2012171725A2 (en) * 2011-06-16 2012-12-20 Unilever Plc Aqueous gels
CN104945448B (zh) * 2015-05-22 2018-06-19 上海绿谷制药有限公司 一种氧化型β-1,4-寡聚葡萄糖醛酸及其制备方法和用途
WO2017206131A1 (en) * 2016-06-02 2017-12-07 Gunze Limited Medical fiber structure and medical laminate
KR102294257B1 (ko) * 2019-04-30 2021-08-26 한양대학교 에리카산학협력단 바이오셀룰로오스-펩티드 복합체 및 이의 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE360128C (de) * 1921-01-03 1922-09-29 Albert Reychler Dr Verfahren zur Herstellung von Staerkeloesungen
US2517772A (en) * 1945-05-11 1950-08-08 Parke Davis & Co Neutralized oxidized cellulose products
US3598622A (en) * 1969-02-19 1971-08-10 Cpc International Inc Alkali treated starch compositions
AR243204A1 (es) * 1986-11-21 1993-07-30 Ajorca Sa Un metodo para la depolimerizacion quimica de polisacaridos.
CA2033046C (en) * 1990-01-12 1999-08-03 Lowell Saferstein Process for preparing a neutralized oxidized cellulose product and its method of use
CN1035803C (zh) * 1990-07-24 1997-09-10 中国化工进出口总公司 可溶性止血织物
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
JP3357996B2 (ja) * 1993-03-26 2002-12-16 ライオン株式会社 金属イオン封鎖性オリゴマー化合物の製造方法及びそのオリゴマー化合物を含む洗浄剤組成物
US5414079A (en) * 1993-08-03 1995-05-09 Biocontrol Incorporated Oxidized cellulose
DE4411681A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verfahren zur Herstellung niedermolekularer Polysaccharidether

Also Published As

Publication number Publication date
HUP9903404A3 (en) 2001-03-28
GB9613683D0 (en) 1996-08-28
PT907664E (pt) 2000-12-29
CA2258849A1 (en) 1998-01-08
ATE195742T1 (de) 2000-09-15
JP5208707B2 (ja) 2013-06-12
PL189194B1 (pl) 2005-07-29
GR3034853T3 (en) 2001-02-28
DE69702911T2 (de) 2001-02-22
HUP9903404A2 (hu) 2000-03-28
EP0907664B1 (en) 2000-08-23
BR9710003A (pt) 2000-01-11
AU3269397A (en) 1998-01-21
CA2258849C (en) 2008-01-22
CZ294839B6 (cs) 2005-03-16
KR20000022286A (ko) 2000-04-25
CZ427498A3 (cs) 1999-05-12
AU725296B2 (en) 2000-10-12
GB2314840B (en) 2000-09-06
EP0907664A1 (en) 1999-04-14
JP2000514110A (ja) 2000-10-24
PL330825A1 (en) 1999-06-07
WO1998000446A1 (en) 1998-01-08
DE69702911D1 (de) 2000-09-28
JP2009102645A (ja) 2009-05-14
JP4302187B2 (ja) 2009-07-22
GB2314840A (en) 1998-01-14

Similar Documents

Publication Publication Date Title
DE69702911D1 (de) Oxydierte oligosaccharide
ES2127831T3 (es) Unidades de expresion multicistronicas y su aplicacion.
DE68914355D1 (de) Manschette aus Polymer für chirurgische Instrumente.
MX9709874A (es) N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN.
DE69029257D1 (de) Anordnung zur bestrahlung von laserstrahlen
BG104247A (bg) Производни на резорцинола
DE59400782D1 (de) Schaft für medizinische Instrumente
ES2162681T3 (es) Conjugados de acido cis-docosahexaenoico y paclitaxel.
GT198302091A (es) Activador de plasminogeno de tejido humano a),b),c).
FI904851A0 (fi) Radiomaerkta antikoagulantpeptider.
FR2731013B1 (fr) Vih-1 de groupe o, fragments desdits virus, ainsi que leurs applications
AR016389A1 (es) Composicion cosmetica que contiene una dispersion acuosa de polimero y una emulsion de silicona disilanol y procedimiento.
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
ES2054944T3 (es) Bis-(tri-t-alquilfenoxi) difosfaespiroundecanos.
BR9915955A (pt) Composição cosmética para cuidado com a pele, processo cosmético para tratar uma pele envelhecida e uso de 4- cromanona
ES2114849T1 (es) Producto y procedimiento para el moldeado permanente del cabello.
DK0743060T3 (da) Anvendelse af tandplejemidler indeholdende bovint colostrum
ES2102284T3 (es) Composicion cosmetica que comprende una asociacion de ceramidas y su utilizacion.
ATE134678T1 (de) Wässrige polymerisatzubereitungen
DK0977871T3 (da) Neurotrypsin
BR9808226A (pt) Coronavìrus respiratório bovino como uma vacina
ATE139541T1 (de) Kollagen-bindendes protein sowie dessen herstellung
TR199802504T2 (xx) N�rotoksik yaralanmalar�n tedavisi i�in bukminsterflirin kullan�lmas�.
ES2141325T3 (es) Composiciones de vidrio para producir fibras de vidrio de dos componentes.
ATE214837T1 (de) Kabelbandage

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 907664

Country of ref document: ES